WebThe 7.5% ACC/AHA treatment threshold is based on an average of control group event rates in primary prevention trials. 2 We recommend statin treatment at a 12% 10-year risk in … WebOverall, therefore, the marked efficacy of atorvastatin in the primary and secondary prevention of cardiovascular events underscores the pivotal place that this statin has in general cardiovascular disease management, and suggests even greater potential clinical utility for the drug in some clinical settings.
Secondary Prevention for Atherosclerotic Cardiovascular …
WebMay 8, 2024 · Despite their high risk of ASCVD, the evidence for primary prevention statin therapy and high‐intensity statin therapy in secondary prevention in older adults is incomplete. 4, 5, 17, 18 Clinical trial data suggest a clinical benefit of moderate‐intensity statins in those aged ≥75 years when used for secondary prevention, and prior … WebMar 30, 2024 · Moderate to high-intensity statin for one of the clear statin-benefit groups after clinician-patient risk discussion (e.g., diabetes, LDL-C ≥190) ... PRIMARY AND … daikin ufficiale
Statin Use and Adverse Effects Among Adults >75 Years of Age: …
WebBackground and aims: To reassess the effect of statin-based lipid-lowering therapy on ischemic stroke in primary and secondary prevention trials with regard to achieved levels of low-density lipoprotein-cholesterol in view of the availability of novel potent hypolipidemic agents. Methods: English literature was searched (up to November 2024) for publications … WebIntroduction. Statins are a mainstay in the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). In survivors of myocardial infarction (MI) and stroke, statins, compared with placebo, reduce rates of recurrent coronary heart disease (CHD) and the need for revascularization procedures. Moreover, mortality is reduced (1). WebMar 5, 2013 · Conclusions. This meta-analysis shows an effect of 18% reduction of all cause mortality when statins are used as secondary prevention, in patients with cardiovascular disease. The effect is less, but still 9% reduction, when statins are used as primary prevention. Statins reduce the occurrence of major coronary events to a similar extent … dailink_comp_array